Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Roberto E. Favoni"'
Autor:
Alessandra Pattarozzi, Elisa Carra, Roberto E. Favoni, Roberto Würth, Daniela Marubbi, Rosa Angela Filiberti, Luciano Mutti, Tullio Florio, Federica Barbieri, Antonio Daga
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-17 (2017)
Abstract Background Malignant pleural mesothelioma is an aggressive cancer, characterized by rapid progression and high mortality. Persistence of tumor-initiating cells (TICs, or cancer stem cells) after cytotoxic drug treatment is responsible for tu
Externí odkaz:
https://doaj.org/article/61c28e1db69a4536b8527a38b2bd4e2a
Autor:
Giulia Pinton, Warren Thomas, Paolo Bellini, Arcangela Gabriella Manente, Roberto E Favoni, Brian J Harvey, Luciano Mutti, Laura Moro
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14110 (2010)
BACKGROUND: The role of estrogen and estrogen receptors in oncogenesis has been investigated in various malignancies. Recently our group identified estrogen receptor beta (ERβ) expression as an independent prognostic factor in the progression of hum
Externí odkaz:
https://doaj.org/article/92a240234e9d48938183a062a9ec2944
Autor:
Elisa Carra, Tullio Florio, Roberto Würth, Rosa Filiberti, Roberto E. Favoni, Antonio Daga, Daniela Marubbi, Federica Barbieri, Luciano Mutti, Alessandra Pattarozzi
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-17 (2017)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Malignant pleural mesothelioma is an aggressive cancer, characterized by rapid progression and high mortality. Persistence of tumor-initiating cells (TICs, or cancer stem cells) after cytotoxic drug treatment is responsible for tumor relap
Publikováno v:
British Journal of Pharmacology. 166:532-553
The incidence of human malignant pleural mesothelioma (hMPM) is still increasing worldwide. hMPM prognosis is poor even if the median survival time has been slightly improved after the introduction of the up-to-date chemotherapy. Nevertheless, large
Autor:
Tullio Florio, Carola Porcile, Alessandra Pattarozzi, Monica Gatti, Antonio Daga, Michele Lo Casto, Daniela Marubbi, Maria Cristina Capra, Federica Barbieri, Renato Spaziante, Roberto E. Favoni, Fabrizio Griffero, Adriana Bajetto, Giorgio Corte, Alice Melotti, Gianluigi Zona
Publikováno v:
Journal of Biological Chemistry. 284:7138-7148
Because a subpopulation of cancer stem cells (tumor-initiating cells, TICs) is believed to be responsible for the development, progression, and recurrence of many tumors, we evaluated the in vitro sensitivity of human glioma TICs to epidermal growth
Autor:
Monica Gatti, Roberto Würth, Adriana Bajetto, Tullio Florio, Alessandra Ratto, Carola Porcile, Angelo Ferrari, Roberto E. Favoni, Federica Barbieri, Alessandra Pattarozzi, G. Lunardi
Publikováno v:
Molecular Pharmacology. 73:191-202
The coordinated activity of estrogens and epidermal growth factor receptor (EGFR) family agonists represents the main determinant of breast cancer cell proliferation. Stromal cell-derived factor-1 (SDF-1) enhances extracellular signal-regulated kinas
Publikováno v:
Pharmacological Research. 39:335-344
The rationale underlying therapeutic strategies designed to inhibit the action of endogenous sex hormones in malignant breast cells is provided by the demonstration of their involvement in supporting the development and growth of breast carcinoma. Th
Autor:
Alessandra de Cupis, Alessandra Ferrera, P. Pirani, Marina Ciomei, Roberto E. Favoni, Andrea Ardizzoni
Publikováno v:
British Journal of Pharmacology. 120:537-543
1. The purpose of this study was to investigate the antiproliferative effect and the modulation of the mitogenic insulin-like growth factor-I (IGF-I) system by FCE 26644 and FCE 27784, two polyanionic sulphonated distamycin A derivative compounds, on
Autor:
Roberto E. Favoni, Tullio Florio, Daniela Marubbi, Alessandra Pattarozzi, Antonio Daga, Federica Barbieri, Elisa Carra
Glioblastomas are grade IV brain tumors characterized by high aggressiveness and invasiveness, giving patients a poor prognosis. We investigated the effects of the multi-kinase inhibitor sorafenib on six cultures isolated from human glioblastomas and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d9276c27da1d7f8d1e55bb79abf4bd
https://europepmc.org/articles/PMC3587450/
https://europepmc.org/articles/PMC3587450/
Autor:
Alessandra Pattarozzi, Tullio Florio, Adriana Bajetto, Roberto Würth, Federica Barbieri, Angelo Ferrari, Roberto E. Favoni, Monica Gatti, Alessandra Ratto
Publikováno v:
Biochemical pharmacology. 82(10)
Malignant pleural mesothelioma (MPM) is an aggressive chemotherapy-resistant cancer. Up-regulation of epidermal growth factor receptor (EGFR) plays an important role in MPM development and EGFR-tyrosine kinase inhibitors (TKIs) may represent novel th